Xenon Pharmaceuticals (NASDAQ:XENE) Downgraded by StockNews.com to “Sell”
StockNews.com cut shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a hold rating to a sell rating in a research report report published on Sunday morning. Several other research firms also recently issued reports on XENE. William Blair reaffirmed an “outperform” rating on shares of Xenon Pharmaceuticals in a research note on Friday, February […]
StockNews.com cut shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a hold rating to a sell rating in a research report report published on Sunday morning. Several other research firms also recently issued reports on XENE. William Blair reaffirmed an “outperform” rating on shares of Xenon Pharmaceuticals in a research note on Friday, February […]